Malaria

Malaria features

• 

  HIV and TB in Practice for nurses: cotrimoxazole prophylaxis

  Cotrimoxazole prophylaxis is the use of a common antiobiotic to prevent a range of infections that commonly affect people living with HIV. ...

  From:  HIV & AIDS treatment in practice

• 

  HIV and malaria: when elephants collide

  Review of the interaction between HIV and malaria, and the prospects for integration of HIV and malaria control activities....

  From:  HIV & AIDS treatment in practice

• 

  WHO calls for an end to the marketing of sub-optimal malaria treatments

  By Theo Smart Two weeks ago the World Health Organization (WHO) called on pharmaceutical companies to “immediately halt” the marketing and sale of ‘single-drug’ artemisinin medicines...

  From:  HIV & AIDS treatment in practice

• 

  HATIP #42, 3rd March 2005

  Is less than 95% adherence to NNRTIs good enough to lead to viral suppression? http://www.aidsmap.com/en/news/4007926C-60CE-4A3D-9CB5-69753377ED26.asp?hp=1 Adherence to nonnucleoside reverse transcriptase inhibitor (NNRTI) regimens does not need to...

  From:  HIV & AIDS treatment in practice

Malaria news from aidsmap

• Lopinavir/ritonavir equivalent to nevirapine in Ugandan children

  A ritonavir-boosted lopinavir (LPV/r)-based regimen achieved a comparable rate of virologic suppression when compared to a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen in HIV-infected Ugandan children at 48 weeks, with comparable immunological responses and adverse events, researchers reported at the ...

  14 March 2013 | Carole Leach-Lemens

• Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation

  Children on ART for more than two years who continued taking daily cotrimoxazole had significantly fewer hospitalisations for malaria as well as for non-malarial infections (notably pneumonia, sepsis and meningitis), compared to children who stopped this treatment, researchers from Uganda ...

  06 March 2013 | Carole Leach-Lemens

• Preventing malaria and diarrhoea delays need for antiretroviral therapy

  The distribution of long-lasting insecticide-treated nets and water filters to prevent malaria and water-borne diseases can significantly reduce the rate of HIV disease progression among Kenyan adults not yet eligible for treatment, an international research group reported on Wednesday ...

  26 July 2012 | Keith Alcorn

• Lopinavir/ritonavir cuts malaria risk in children with HIV

  HIV-infected children in Tororo, Uganda, an area of high malaria transmission, on a lopinavir/ritonavir (LPV/r, or Kaletra)-based antiretroviral (ART) regimen had a significantly lower risk of getting malaria, compared to those on a non-nucleoside reverse transcriptase (NNRTI)-based regimen, researchers reported ...

  07 March 2012 | Carole Leach-Lemens

• Symptoms of primary HIV infection often mistaken for malaria, representing missed opportunity for testing and prevention

  Almost two-thirds of a cohort of Kenyans newly infected with HIV had sought treatment for fever, and 40% of these received presumptive treatment for malaria, but only 12% were tested for HIV, highlighting important missed opportunities for diagnosis and prevention ...

  28 April 2011 | Carole Leach-Lemens

• Cotrimoxazole better at preventing malaria than standard preventive treatment in pregnant women with HIV

  Daily cotrimoxazole treatment significantly reduced malaria parasitaemia and anaemia in pregnant women with HIV infection when compared to intermittent preventive treatment with sulfadoxine-pyrimethamine, a study in Malawi has found. The findings are published in advance online by the Journal of ...

  14 January 2011 | Keith Alcorn

• Breastfeeding reduces risk of malaria in infants with HIV

  In HIV-exposed and HIV-infected infants aged six to 15 months breastfeeding significantly lowered the risks of getting malaria according to Neil Vora and colleagues in a prospective study of infants in Tororo, a high malaria transmission rural area in ...

  25 August 2010 | Carole Leach-Lemens

• Cotrimoxazole cuts mortality for symptomatic patients with HIV in areas with low malaria prevalence

  Starting treatment with the antibiotic cotrimoxazole at the same time as antiretroviral therapy reduces mortality by over a third amongst patients with HIV, South African investigators report in the July 17th edition of AIDS. Reductions in ...

  06 July 2010 | Michael Carter

• Malaria symptoms should raise suspicion of HIV in sub-Saharan Africa

  Screening for HIV in people who present with suspected malarial fever could identify large numbers of very recent HIV infections in countries with a high HIV burden, and could represent an effective way of integrating HIV ...

  28 June 2010 | Carole Leach-Lemens

• Cheap antibiotic halves risk of death in first 18 months of antiretroviral treatment

  Use of cotrimoxazole, a cheap and widely available antibiotic, cut the death rate by half in the first 72 weeks on antiretroviral therapy in over 3000 HIV-infected, symptomatic and severely immunosuppressed patients in Uganda and Zimbabwe, ...

  01 April 2010 | Carole Leach-Lemens

More news

Malaria news selected from other sources

• Malaria and HIV Spike as Greece Cuts Healthcare Spending

  Greece's budgetary ax fell unduly hard on its healthcare sector, which was slated to grow at around 4 percent annually, but which has instead been jolted by a series of wage freezes, firings, and drug rationing programs.

  16 May 2013 | The Atlantic

• Canada commits cash to Global Fund against AIDS, tuberculosis, malaria

  Canada’s Minister of International Co-operation Julian Fantino on Monday provided another $20 million to the Global Fund to support affordable medicines facilities for malaria.

  15 May 2013 | Toronto Star

• Malaria Bednet Distribution in Sub-Saharan Africa Is About Half of What Is Needed

  Of the approximately 80 million insecticide-treated nets distributed through Global Fund–supported programmes in 2012, about 66 million (73%) went to sub-Saharan African countries. This is well below half the 150 million insecticide-treated nets that the World Health Organisation estimates are needed annually to protect all populations at risk of malaria in this region.

  09 April 2013 | Global Fund Observer

• Follow-up study describes declining efficacy of malaria vaccine candidate over 4 years

  Long-term follow-up of a phase II study from KEMRI-Wellcome Trust Research Programme and Oxford University researchers in Kenya shows that the efficacy of a malaria vaccine candidate, RTS,S, wanes over time and varies with exposure to the malaria parasite.

  21 March 2013 | Eurekalert Inf Dis

• Prezista (darunavir) label change - drug interaction information

  The FDA recently approved changes to the Prezista (darunavir) label to reflect drug interaction information with artemether/lumefantrine. The specific changes are outlined below.

  02 March 2013 | US Food and Drug Administration

• US budget cuts could jeopardize development of life-saving tools against major killers

  Across-the-board cuts to US R&D programs could have a devastating impact on efforts to develop new drugs for tuberculosis and HIV/AIDS, the world's first malaria vaccine, and other vital global health products in development, according to a new report from a coalition of nonprofit groups focused on advancing innovation to save lives.

  27 February 2013 | Eurekalert Inf Dis

• Research suggests malaria can be defeated without a globally led eradication program

  A researcher at the University of Southampton, working as part of a team from the UK and USA, believes the global eradication of malaria could be achieved by individual countries eliminating the disease within their own borders and coordinating efforts regionally. The team's findings have been published in the journal Science.

  27 February 2013 | Eurekalert Inf Dis

• The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013

  Applying sequestration cuts to US government global health programming would have minimal impact on deficit reduction, but would be devastating to the lives of many thousands of people globally.

  19 February 2013 | AmFAR

• Uganda: Health Ministry Sets New Treatment Guidelines

  The health ministry has released new national clinical guidelines for the management of common conditions. It also released new essential medicines and health supplies list for HIV/AIDS, malaria, TB, pneumonia and diarrhoea in children.

  01 February 2013 | AllAfrica

• Dr. Mark Dybul: The Big Push to Defeat AIDS, TB and Malaria

  Every era offers something special. I think the most special thing about our current time is the incredible opportunity that scientific advances have provided in the field of global health, giving us the ability to completely control highly dangerous infectious diseases such as AIDS, tuberculosis and malaria.

  23 January 2013 | Huffington Post

More news